Circulating angiopoietin-2 and angiogenic microRNAs associate with cerebral small vessel disease and cognitive decline in older patients reaching end-stage renal disease
- 23 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 37 (3) , 498-506
Abstract
Background: The prevalence of end-stage renal disease (ESRD) is increasing worldwide, with the majority of new ESRD cases diagnosed in patients >60 years of age. These older patients are at increased risk for impaired cognitive functioning, potentially through cerebral small vessel disease (SVD). Novel markers of vascular integrity may be of clinical value for identifying patients at high risk for cognitive impairment. Methods: We aimed to associate the levels of angiopoietin-2 (Ang-2), asymmetric dimethylarginine and a selection of eight circulating angiogenic microRNAs (miRNAs) with SVD and cognitive impairment in older patients reaching ESRD that did not yet initiate renal replacement therapy (n = 129; mean age 75.3 years, mean eGFR 16.4 mL/min). We assessed brain magnetic resonance imaging changes of SVD (white matter hyperintensity volume, microbleeds and the presence of lacunes) and measures of cognition in domains of memory, psychomotor speed and executive function in a neuropsychological test battery. Results: Older patients reaching ESRD showed an unfavourable angiogenic profile, as indicated by aberrant levels of Ang-2 and five angiogenic miRNAs (miR-27a, miR-126, miR-132, miR-223 and miR-326), compared with healthy persons and patients with diabetic nephropathy. Moreover, Ang-2 was associated with SVD and with the domains of psychomotor speed and executive function, while miR-223 and miR-29a were associated with memory function. Conclusions: Taken together, these novel angiogenic markers might serve to identify older patients with ESRD at risk of cognitive decline, as well as provide insights into the underlying (vascular) pathophysiology.Keywords
Funding Information
- Dutch Kidney Foundation
- European Foundation for the Study of Diabetes
- Dutch Heart Foundation in the context of the CVON consortium RECONNECT and to M.J.P.V.O., M.A.V.B., E.E.B. and H.C.A. in the context of the CVON consortium Heart Brain Connection
This publication has 57 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- MicroRNA-223 is neuroprotective by targeting glutamate receptorsProceedings of the National Academy of Sciences, 2012
- miRNA-132: a dynamic regulator of cognitive capacityBrain Structure and Function, 2012
- Microglia and Memory: Modulation by Early-Life InfectionJournal of Neuroscience, 2011
- Clinical Interaction between Brain and Kidney in Small Vessel DiseaseCardiology Research and Practice, 2011
- Effects of Adult Age and Blood Pressure on Executive Function and Speed of ProcessingExperimental Aging Research, 2010
- Circulating angiopoietin-2 levels increase with progress of chronic kidney diseaseNephrology Dialysis Transplantation, 2010
- Visual association test to detect early dementia of the Alzheimer typeJournal of Neurology, Neurosurgery & Psychiatry, 2002
- A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imagingJournal of the Neurological Sciences, 1993
- Learning and Retrieval Rate of Words Presented Auditorily and VisuallyThe Journal of General Psychology, 1985